Editorial of the Special Issue: Oncolytic Viruses as a Novel Form of Immunotherapy for Cancer

被引：6
作者：
Guo, Zong Sheng [1 ]
Bartlett, David L.
机构：
[1] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15213 USA
来源：
BIOMEDICINES | 2017年 / 5卷 / 03期
关键词：
NEWCASTLE-DISEASE VIRUS; IMMUNITY; VACCINE;
D O I：
10.3390/biomedicines5030052
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：5
相关论文
共 25 条
[21]   Fifty Years of Clinical Application of Newcastle Disease Virus: Time to Celebrate! [J].
Schirrmacher, Volker .
BIOMEDICINES, 2016, 4 (03)
[22]   Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal cancer patients following resection of liver metastases: results of a prospective randomized trial [J].
Schulze, T. ;
Kemmner, W. ;
Weitz, J. ;
Wernecke, K. -D. ;
Schirrmacher, V. ;
Schlag, P. M. .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2009, 58 (01) :61-69
[23]   Recombinant Poxvirus and the Tumor Microenvironment: Oncolysis, Immune Regulation and Immunization [J].
Sharp, DanielW. ;
Lattime, Edmund C. .
BIOMEDICINES, 2016, 4 (03)
[24]   Herpes simplex virus as an in situ cancer vaccine for the induction of specific anti-tumor immunity [J].
Toda, M ;
Rabkin, SD ;
Kojima, H ;
Martuza, RL .
HUMAN GENE THERAPY, 1999, 10 (03) :385-393
[25]   Autophagy, Inflammation, and Immunity: A Troika Governing Cancer and Its Treatment [J].
Zhong, Zhenyu ;
Sanchez-Lopez, Elsa ;
Karin, Michael .
CELL, 2016, 166 (02) :288-298
123